Istalab 50 Tablet is a specialized formulation containing Sitagliptin Phosphate I.P. at a dosage of 50 mg. This medication is primarily indicated for the management of type 2 diabetes mellitus in adults. Sitagliptin is classified as a DPP-4 (dipeptidyl peptidase-4) inhibitor, which plays a crucial role in enhancing the body’s ability to regulate blood sugar levels. It works by increasing the levels of incretin hormones, which are responsible for stimulating insulin secretion in response to meals and reducing glucagon secretion, thereby lowering glucose production in the liver.
The therapeutic action of Istalab Tablet makes it particularly beneficial for patients who struggle to achieve adequate glycemic control through diet and exercise alone. It can be used as a monotherapy or in combination with other antidiabetic agents, such as metformin or sulfonylureas, to provide a more comprehensive approach to diabetes management. The convenience of a once-daily dosing regimen enhances patient adherence, making it easier for individuals to incorporate this medication into their daily routine.
While Istalab Tablet is generally well-tolerated, some patients may experience side effects. Common adverse reactions include headache, dizziness, and gastrointestinal issues such as nausea, diarrhea, or abdominal discomfort. In rare cases, more serious side effects may occur, including pancreatitis or severe allergic reactions. Patients should be advised to monitor for any unusual symptoms and report them to their healthcare provider promptly.
For optimal storage, Istalab Tablet should be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to store this medication out of reach of children and pets to prevent accidental ingestion.